These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280 [Abstract] [Full Text] [Related]
9. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases]. Belhadj Chaidi R, Thollot C, Ferru A, Roblot P, Landron C. J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202 [Abstract] [Full Text] [Related]
11. Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants? Kartsios C, Lokare A, Osman H, Perrin D, Razaq S, Ayub N, Daddar B, Fair S. J Thromb Thrombolysis; 2021 May; 51(4):947-952. PubMed ID: 32910408 [Abstract] [Full Text] [Related]
12. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. Lu X, Lin J. BMC Musculoskelet Disord; 2018 Sep 08; 19(1):322. PubMed ID: 30193575 [Abstract] [Full Text] [Related]
13. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Hillis C, Crowther MA. Thromb Haemost; 2015 Jun 08; 113(6):1193-202. PubMed ID: 25948149 [Abstract] [Full Text] [Related]
14. Incidence of venous thromboembolism in hospitalized patients with COVID-19. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. J Thromb Haemost; 2020 Aug 08; 18(8):1995-2002. PubMed ID: 32369666 [Abstract] [Full Text] [Related]
15. Venous thromboembolism and anticoagulant therapy in pregnancy. Greer IA. Gend Med; 2005 Aug 08; 2 Suppl A():S10-7. PubMed ID: 16551552 [Abstract] [Full Text] [Related]
16. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism. Bellmunt-Montoya S, Riera C, Gil D, Rodríguez M, García-Reyes M, Martínez-Carnovale L, Marrero C, Gil M, Ruiz-Rodríguez JC, Ferrer R, de Nadal M, Monreal M, Llagostera S. Eur J Vasc Endovasc Surg; 2021 Apr 08; 61(4):628-634. PubMed ID: 33583710 [Abstract] [Full Text] [Related]
17. [The optimal duration of anticoagulant treatment following pulmonary embolism]. Couturaud F. Rev Mal Respir; 2011 Dec 08; 28(10):1265-77. PubMed ID: 22152935 [Abstract] [Full Text] [Related]
18. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR. Thromb Haemost; 2009 Apr 08; 101(4):762-9. PubMed ID: 19350123 [Abstract] [Full Text] [Related]
19. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries. Ahmed HY, Papali A, Haile T, Shrestha GS, Schultz MJ, Lundeg G, Akrami KM, COVID-LMIC Task Force and the Mahidol-Oxford Research Unit (MORU). Am J Trop Med Hyg; 2021 Jan 11; 104(3_Suppl):99-109. PubMed ID: 33432908 [Abstract] [Full Text] [Related]
20. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient). Pernod G, Joly M, Sonnet B. J Med Vasc; 2020 Nov 11; 45(6S):6S17-6S23. PubMed ID: 33276939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]